نتایج جستجو برای: prostate radiotherapy

تعداد نتایج: 157351  

H.J. Kim, J.H. Phak, W.Ch. Kim,

Background: stereotactic body radiotherapy (SBRT) has emerged as an effective treatment for localized prostate cancer. However, prostate-specific antigen (PSA) kinetics after SBRT has not been well characterized. The objective of the current study is to analyze the rate of PSA decline and PSA nadir following hypofractonated SBRT in localized prostate cancer. Materials and Methods: From 2008...

2014
Prasanna Sooriakumaran Tommy Nyberg Olof Akre Leif Haendler Inge Heus Mats Olsson Stefan Carlsson Monique J Roobol Gunnar Steineck Peter Wiklund

OBJECTIVE To compare the survival outcomes of patients treated with surgery or radiotherapy for prostate cancer. DESIGN Observational study. SETTING Sweden, 1996-2010. PARTICIPANTS 34,515 men primarily treated for prostate cancer with surgery (n=21,533) or radiotherapy (n=12,982). Patients were categorised by risk group (low, intermediate, high, and metastatic), age, and Charlson comorbid...

A.K. Bhardwaj, A.S. Oinam, S.C. Sharma, S.K. Chakarvarti, T.S. Kehwar,

 Background: To analyze the dosimetric and radio biologic advantages between intensity modulated radiotherapy (IMRT) and 3 dimensional conformal radiotherapy (3DCRT) and selection of optimal photon energy for IMRT treatments. Material and methods: 24 patients with localized prostate carcinoma were planned for 3DCRT and IMRT techniques. Radiation dose of 54 Gy with 2 Gy/fraction, was planned to ...

2015
Masaki Shiota Akira Yokomizo Ario Takeuchi Kenjiro Imada Keijiro Kiyoshima Junichi Inokuchi Katsunori Tatsugami Saiji Ohga Katsumasa Nakamura Hiroshi Honda Seiji Naito

Radiotherapy for prostate cancer is associated with an increased incidence of secondary bladder cancer (BC). We investigated the incidence, clinicopathological characteristics, and prognosis of BC after radiotherapy, surgical therapy, and primary androgen-deprivation therapy (ADT) for prostate cancer. This study included 1,334 Japanese patients with prostate cancer treated with radiotherapy (n=...

A.M. Serafin, J.M. Akudugu, S. Maleka,

Background: Radiotherapy and adjuvant androgen deprivation therapy have historically been the first treatment choices for prostate cancer but treatment resistance often limits the capacity to effectively manage the disease. Therefore, alternative therapeutic approaches are needed. Here, the efficacies of radiotherapy and targeting the pro-survival cell signaling components epidermal growth fact...

Journal: :Japanese journal of clinical oncology 2011
Takahiro Yoshida Masashi Nakayama Osamu Suzuki Kyosuke Matsuzaki Yasuyuki Kobayashi Ken Takeda Yasuyuki Arai Ken-ichi Kakimoto Kinji Nishiyama Kazuo Nishimura

OBJECTIVE The aim of this study was to investigate the efficacy and prognostic factors of salvage radiotherapy for prostate-specific antigen relapse after radical prostatectomy for prostate cancer at a single center in Japan. METHODS A retrospective review of the medical records of 51 patients who underwent salvage radiotherapy for prostate-specific antigen relapse after radical prostatectomy...

2010
Noriyuki Suzuki Masaki Shimbo Yoshiyasu Amiya Susumu Tomioka Takayuki Shima Shino Murakami Hiroomi Nakatsu Sayako Oota Jun Shimazaki

OBJECTIVE Management of lymph nodes in radiotherapy for prostate cancer is an issue for curative intent. To find the influence of lymph nodes, patients with T1-T3 prostate cancer and surgically confirmed negative nodes were treated with radiotherapy. METHODS After lymphadenectomy, 118 patients received photon beam radiotherapy with 66 Gy to the prostate. No adjuvant treatment was performed un...

2015
Nam P. Nguyen Rick Davis Satya R. Bose Suresh Dutta Vincent Vinh-Hung Alexander Chi Juan Godinez Anand Desai William Woods Gabor Altdorfer Mark D’Andrea Ulf Karlsson Richard A. Vo Thomas Sroka

Patients with early stage high-risk prostate cancer (prostate specific antigen > 20, Gleason score > 7) are at high risk of recurrence following prostate cancer irradiation. Radiation dose escalation to the prostate may improve biochemical-free survival for these patients. However, high rectal and bladder dose with conventional three-dimensional conformal radiotherapy may lead to excessive gast...

Journal: :iranian journal of radiation research 0
m. vakilha radiation-oncology dept., tehran university of medical sciences, tehran, iran f.n. dadgar t. tirgari

leiomyosarcoma is a rare entity in prostate but it is the most common type of prostate sarcomas in adult patients. in most reported series the prognosis is poor and the median survival is about 15-18 months. hereby we present a 72 years old man who received combined modality treatment including radical surgery followed by adjuvant chemotherapy and radiotherapy. he has been well for 14 months, b...

2013
Eliahu Gez Shmuel Cytron Rahamin Ben Yosef Daniel London Benjamin W Corn Shlomi Alani Giovanni Scarzello Fabrizio Dal Moro Guido Sotti Filiberto Zattoni Ike Koziol Taryn Torre Matthew Bassignani Shalom Kalnicki Reza Ghavamian Dukagjin Blakaj Mitchell Anscher Martin Sommerauer Dieter Jocham Corinna Melchert Stefan Huttenlocher Gyoergy Kovacs Madhur Garg

BACKGROUND AND PURPOSE Rectal toxicity presents a significant limiting factor in prostate radiotherapy regimens. This study evaluated the safety and efficacy of an implantable and biodegradable balloon specifically designed to protect rectal tissue during radiotherapy by increasing the prostate-rectum interspace. PATIENTS AND METHODS Balloons were transperineally implanted, under transrectal ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید